Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2016 Volume 12 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2016 Volume 12 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation

  • Authors:
    • Lin Gan
    • Lan Yu
    • Manying Xie
    • Wei Feng
    • Jiabao Yin
  • View Affiliations / Copyright

    Affiliations: Department of Ultrasound Imaging, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China
    Copyright: © Gan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3323-3327
    |
    Published online on: September 23, 2016
       https://doi.org/10.3892/etm.2016.3745
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the study was to examine changes in left atrial appendage volume (LAA-V) in patients with non-valvular atrial fibrillation (AF) using real-time three-dimensional transesophageal echocardiography (RT3D-TEE) and evaluate the prediction value on the high risk of thrombosis of LAA. Using RT3D-TEE we measured: i) LAA peak empty velocity (LAA‑PEV), ii) LAA-V including LAA end-diastolic volume (LAA‑EDV) and end-systolic volume (LAA-ESV). We also calculated LAA ejection fraction (LAA-EF). RT3D-TEE was applied in 20 control cases and 74 patients with non‑valvular AF. According to the presence of thrombosis, 74 patients were divided into the no thrombosis group (NTH group, n=52) and thrombosis group (TH group, n=22). Our results showed that there were significant differences in LAA-V and LAA-EF values in different groups (P<0.05). LAA-EDV moderately correlated with LAA-PEV (r=-0.531, P<0.001) while LAA-ESV demonstrated a strong correlation with LAA-PEV (r=-0.741, P<0.001). LAA-EF also showed a strong correlation with LAA-PEV (r=0.693, P<0.001). Through receiver operating characteristic (ROC) curves, the cut-off values of LAA-EDV and LAA-ESV in thrombosis of LAA were 18.45 and 9.69 ml, respectively. RT3D-TEE effectively evaluated the LAA-V, LAA-PEV and LAA-EF parameters, and proved to be valuable in the process of evaluation of thrombosis of LAA.

Introduction

Atrial fibrillation (AF) is a condition involving an irregular heart rhythm, known as arrhythmia. It is the most common type of arrhythmia (1). The most common conditions leading to AF are: i) rheumatic valvular disease, ii) coronary heart disease, and iii) hypertensive heart disease. AF is the main risk factor inducing cardiogenic strokes (2). Increased pressure and blood stagnation occurred in AF, due to the particular anatomical structure of the left atrial appendage, which is the narrowest part in the left atrium with the roughest endocardial surface. Therefore thrombus easily occurs in the left atrial appendage, and in previous studies, length, width, emptying rate and other indicators were employed to evaluate its function (3).

In the present study, we measured the left atrial appendage volume (LAA-V) through real-time three-dimensional transesophageal echocardiography (RT3D-TEE) to calculate LAA ejection fraction (LAA-EF). Subsequently, the association between the changes in LAA-V, LAA-EF and thrombosis when LAA occurred was analyzed. These analyses provided valuable information pertaining to patients with a high risk of thrombosis and guided our clinical treatment and reduced the occurrence of LAA and cardiogenic stroke.

Materials and methods

Research object

From September, 2014 to December, 2014, 74 patients diagnosed with AF at the Xiangyang Hospital Affiliated to Hubei University of Medicine (Hubei, China), were selected. Patients with valvular heart diseases were excluded. There were 32 men and 42 women, with an age range of 34–76 years (average, 58.86±9.85 years). Of the 74 cases, 26 suffered from persistent AF while 48 had paroxysmal AF. According to the results obtained through ultrasonic cardiogram and clinical examinations all 74 cases were diagnosed with AF. There were 3 groups: i) the LAA thrombosis group (TH group) with 22 cases, ii) the non-LAA thrombosis group (NTH group) with 52 cases, and iii) the control group with 20 randomly chosen patients from our hospital. Patients in the control group comprised 10 men and 10 women (average age, 44.21±12.29 years), who did not have AF.

Apparatus and method

Philips iE33 color Doppler ultrasonic diagnostic apparatus was used (Philips, Eindhoven, The Netherlands). Patients were detected using TTE, connected to the electrocardiogram, to have the information related to their heart size, morphology, structure and function. Informed consent was obtained from the patients. Approval of the study was obtained by the ethics committee of the Xiangyang Hospital Affliated to Hubei University of Medicine. TEE (X7-2t probe, 2–7 MHz) was used. After TEE, patients fasted for >8 h with no water for >4 h. In cases with dentures they were removed at the same time. On the examination of TEE, the patients with local anesthesia of lidocaine hydrochloride were examined in the left lateral decubitus position, biting mouthparts were placed in their oral cavity, and probe X7-2t was sent into the esophagus to scan each section of left atrial appendage in the middle of the esophagus, to observe thrombosis and measure LAA peak empty velocity (LAA-PEV). Then full-volume was initiated, five cardiac cycles were stored, and QLAB 9.0 software (Philips Medical System, Andover, MA, USA) was applied in the analysis.

Measurement index
LAA-PEV

In the middle of the TEE esophagus, approximately 45°, a long axis of the left atrial appendage was displayed, a pulse-waved (PW) Doppler was applied in placing the sample volume at the central position with <1 cm the distance from the left atrial appendage entrance to obtain a spectrogram, and forward wave in the beginning of P-wave in patients with sinus rhythm, the peak velocity of which was LAA-PEV. In the AF patients, the average value of maximum forward velocity in each cardiac cycle of five cardiac cycles was LAA-PEV.

LAA end-diastolic volume (LAA-EDV), LAA end-systolic volume (LAA-ESV) and LAA-EF

The full-volume image was opened by GI3DQ plugin and the target area was adjusted, as there were three perpendicular sections of LAA, two long axis section and a transverse section (Fig. 1A-C). One of the long axis sections was selected, stacked contours button was clicked, and the software automatically measured the vertical distance from the entrance to the top of LAA. A long axis section was cut into several layers of equidistant cross sections (adjustable 3–16 layers, Fig. 1B), and the contour of each depicting cross section was shown. The instrument then automatically generated the 3D image of LAA and computed the LAA-V (Fig. 1D).

Figure 1.

Measurement of LAA-V by GI3DQ. (A-C) Three orthogonal planes of LAA-V, (A and B) the long axis cross section of LAA-V, (C) the cross section of LAA-V, and (D) three-dimensional image of LAA-V. LAA-V, left atrial appendage volume.

The measurement of LAA-EDV and LAA-ESV

Patients with sinus rhythm were detected, respectively, in the beginning of P-wave and in the end of QRS wave. The mean values of the maximum volume and the minimum volume in each cardiac cycle of 5 consecutive cardiac cycles were measured in patients with AF. Subsequently, LAA-EF was calculated using the following formula: (LAA-EDV-LAA-ESV)/(LAA-EDV).

Statistical analysis

SPSS 18.0 software package (Chicago, IL, USA) was used for data processing. Data were expressed as mean ± standard deviation (SD). One-way analysis of variance (ANOVA) was employed in the comparison of multiple sets of measurement data. LSD methods were used to compare between two mean values of multiple sets of mean values. Pearson's method was applied to compare LAA-PEV, LAA-V and LAA-EF. Receiver operating characteristic (ROC) curve was used in the prediction of cut-off values of the left atrial appendage thrombus through LAA-EDV and LAA-ESV. P<0.05 was considered statistically significant.

Results

Left atrial thrombosis

Of the 74 patients with AF, 22 cases had LAA thrombus by TEE, flat or papillary, 2.0×3.3 mm to 8.9×5.7 mm. Of the 22 cases, 14 cases were fresh thrombus with weak and low echo, and 8 cases had organized thrombus with strong echo (Fig. 2), 10 cases were located in the pectinate muscles at the top of LAA, 7 cases were located on the lateral wall of LAA, and 5 cases were located on the medial wall of left atrial appendage. After thrombolytic therapy for 3–5 months, LAA thrombus of 14 patients disappeared through TEE review, and left atrial appendage thrombus of 8 patients was significantly shrunk.

Figure 2.

Left atrial thrombus. LA, atrium sinistrum; LV, ventriculus sinister; LAA, left atrial appendage; the yellow arrow, left atrial appendage thrombus.

Comparison of ultrasonic measurement values of LAA

The comparison of parameters in the three groups is shown in Table I. Differences between the LAA-PEV and LAA-EF, NTH group and TH group were statistically significant (P<0.05). Differences between LAA-EDV and LAA-ESV in all 3 groups were statistically significant (P<0.05).

Table I.

Measurement value of the left atrial appendage in the three groups.

Table I.

Measurement value of the left atrial appendage in the three groups.

GroupsCasesLAA-PEV (cm/s)LAA-EDV (ml)LAA-ESV (ml)LAA-EF (%)
Control group2077.08±21.029.18±2.542.41±1.4174.50±12.03
NTH group5270.28±32.58 13.56±3.69a 5.58±2.24a 59.53±9.55a
TH group22 43.90±22.09a,b 20.61±5.74a,b 10.72±3.93a,b 47.82±15.44a,b
F-value 5.93320.46726.06912.712
P-value 0.005<0.001<0.001<0.001

{ label (or @symbol) needed for fn[@id='tfn1-etm-0-0-3745'] } Compared with the control group

a P<0.05; compared with the NTH group

b P<0.05. LAA-PEV, left atrial appendage peak empty velocity; LAA-EDV, left atrial appendage end-diastolic volume; LAA-ESV, left atrial appendage end-systolic volume; LAA-EF, left atrial appendage ejection fraction.

Association between LAA-PEV and other measurement values

LAA-EDV and LAA-PEV showed a moderate negative correlation (r=−0.531, P<0.001). LAA-PEV and LAA-ESV showed a strong negative correlation (r=−0.741, P<0.001), while LAA-EF and LAA-PEV had a strong positive correlation (r=0.693, P<0.001).

ROC curve analysis of LAA-V

The cut-off values for the forecast of thrombus by LAA-EDV and LAA-ESV were 18.45 and 9.69 ml, area under the curve was 0.896 and 0.807, 95% confidence interval was 0.814–0.978 and 0.693–0.920, respectively (P<0.05) (Fig. 3).

Figure 3.

The prediction of ROC curve of LAA thrombosis by LAA-EDV and LAA-ESV. ROC, receiver operating characteristic; LAA, left atrial appendage; LAA-EDV, LAA end-diastolic volume; LAA-ESV, LAA end-systolic volume.

Discussion

LAA is the remnants of primitive atrium in embryonic period, a narrow and curved pipe, the spire is a narrow blind side, and the body is rich in myocardial cells. These special anatomical features lead to thrombus formed in the left atrial appendage rather than in atrium sinistrum and other structures in left atrial blood flow deposition (4,5). The most common causes of inducing left atrial blood flow deposition are AF. In AF, the coordination between atrial and ventricular is broken. This is combined with the non-coordinated atrial contraction, which induces the atrial blood ejection deficiency and blood flow deposition, and eventually leads to higher atrial volume and pressure (6).

In the case of LAA-V, it is believed that ‘t’ can be used as a predictive value of thromboembolic stroke for patients with AF (7), and studies have found that increased LAA-V and decreased LAA-EF were significantly correlated with paroxysmal AF. The variability of LAA-V observed through the detection of R3D-TEE was small (8). The present study used GI3DQ of Q-lab software to respectively calculate LAA-EDV and LAA-ESV, then calculate LAA-EF. A comparison of LAA-V in all three groups, showed that the control group had the lowest LAA-V and the TH had the highest. Differences were statistically significant. These results indicated that LAA-V increased in AF, and with the increased LAA-V, the risk of suffering from LAA thrombus was also increased. The increase of LAA-V in patients with AF may be due to an increase in left auricle cardiomyocytes in AF and loss of muscle fiber in the cells, which decreased left atrial systolic function, reduced LAA blood ejection (9) and shortened left atrial diastolic and systolic time. The two factors lead to blood stagnation of the left atrial appendage and increased LAA-V. LAA-V was usually only approximately 10% of the left atrium, but it played an important role in the left atrium function. Compared with the intrinsic atrial, the compliance of LAA was improved; thus, when the pressure and volume of the left atrial increased, LAA acted as a reservoir. This was the reason for the intrinsic atrial becoming only slightly enlarged in patients with AF, while LAA became significantly expanded (10). In the group of patients with AF combined with left atrial thrombus, conventional transthoracic echocardiography did not show the thrombus. Therefore, conventional TEE examinations in patients with AF were very important.

Previous findings confirmed that formation of LAA thrombus, significantly decreased LAA-PEV (11). A low LAA-PEV value has been proven to increase the risk of LAA thrombus (12). In clinical examinations, we often evaluated the function of the left atrial appendage in patients with AF by measuring LAA-PEV. It is believed that LAA-PEV are independent risk factors in the formation of LAA thrombus (13). The present study has shown that LAA-V and LAA-PEV were negatively correlated and changes in LAA function reflected by LAA-V and hemodynamics changes reflected by LAA-PEV were similar. Additionally, according to the ROC curve, and area under the curve (AUC), the cut-off values by LAA-ESV and LAA-EDV were 0.807 and 0.896, respectively, which indicated that use of LAA-V in the assessment of risk of LAA thrombosis had a higher accuracy. Results obtained in the present study were similar with results reported by Tanaka et al on the relationship between LAA-VI and the occurrence of paroxysmal AF in patients with cerebral infarction (8). Tanaka et al evaluated the cut-off point of paroxysmal AF with LAA-VI and obtained higher AUC (8).

Previous findings showed that, compared with the control group, the LAA-EF of patients with non-valvular AF was significantly lower (14). In the present study, the comparison of LAA-EF in three groups through LAA-V showed that, the control group was the highest and the TH group was the lowest. This indicated that the left fibrillation systolic function of patients with fibrillation decreased, and with the reduced systolic function, the risk of thrombus increased. Left fibrillation systolic function was an important factor in affecting left atrial ejection (15); thus, the study on the relationship of LAA-EF and LAA-PEV was significant. This study found that LAA-EF had a strong positive correlation with LAA-PEV, which showed that the measurement of LAA-EF with RT3D-TEE in assessment of left fibrillation function was feasible. Through measurement of the left fibrillation function in patients in acute stage of cerebral infarction, it was found that LAA-EF and LAA-PEV in the paroxysmal AF groups were significantly lower than those of non-AF groups. Through the ROC curve, it was hypothesized that, LAA-EF <49.1% was able to predict the occurrence of paroxysmal AF (16), which provided more information for clinical prognosis and active treatment.

In conclusion, application of RT3D-TEE identified the structure of LAA comprehensively in real-time and evaluated the function of LAA through the measurement of LAA-PEV, LAA-EDV, LAA-ESV and LAA-EF. This method can be used to evaluate the prognosis of patients with non-valvular AF, and reduce the occurrence of cardiac stroke.

References

1 

Nattel S, Li D and Yue L: Basic mechanisms of atrial fibrillation - very new insights into very old ideas. Annu Rev Physiol. 62:51–77. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Iwahana H, Ishikawa S, Ishikawa J, Kabutoya T, Kayaba K, Gotoh T and Kajii E: Atrial fibrillation is a major risk factor for stroke, especially in women: the Jichi Medical School cohort study. J Epidemiol. 21:95–101. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Wysokinski WE, Ammash N, Sobande F, Kalsi H, Hodge D and McBane RD: Predicting left atrial thrombi in atrial fibrillation. Am Heart J. 159:665–671. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Burrell LD, Horne BD, Anderson JL, Muhlestein JB and Whisenant BK: Usefulness of left atrial appendage volume as a predictor of embolic stroke in patients with atrial fibrillation. Am J Cardiol. 112:1148–1152. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, Hasegawa D and Matsuda O: Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J. 28:2217–2222. 2007. View Article : Google Scholar : PubMed/NCBI

6 

Stoddard MF, Dawkins PR, Prince CR and Ammash NM: Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol. 25:452–459. 1995. View Article : Google Scholar : PubMed/NCBI

7 

Santiago D, Warshofsky M, Li MG, Di Tullio M, Coromilas J, Reiffel J and Homma S: Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study. J Am Coll Cardiol. 24:159–164. 1994. View Article : Google Scholar : PubMed/NCBI

8 

Tanaka K, Koga M, Sato K, Suzuki R, Minematsu K and Toyoda K: Three-dimensional analysis of the left atrial appendage for detecting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Stroke. 9:1045–1051. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Li AL, Li ZA, Wang Y, Zeng YJ and Sun CL: Assessment of left atrial appendage function by real-time three-dimensional transesophageal echocardiography. Chinese J Ultrasonography. 19:737–740. 2010.

10 

Nakajima H, Seo Y, Ishizu T, Yamamoto M, Machino T, Harimura Y, Kawamura R, Sekiguchi Y, Tada H and Aonuma K: Analysis of the left atrial appendage by three-dimensional transesophageal echocardiography. Am J Cardiol. 106:885–892. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Demirçelik MB, Çetin M, Çiçekcioğlu H, Uçar Ö and Duran M: Effect of left ventricular diastolic dysfunction on left atrial appendage function and thrombotic potential in nonvalvular atrial fibrillation. Anadolu Kardiyol Derg. 14:256–260. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW and Hart RG: Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation III investigators. J Am Coll Cardiol. 31:1622–1626. 1998. View Article : Google Scholar : PubMed/NCBI

13 

Zateyshchikov DA, Brovkin AN, Chistiakov DA and Nosikov VV: Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation. J Thromb Thrombolysis. 30:192–199. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Bi WJ, Sun FF, Ren WD, Pan FZ, Hu Q and Xu M: Real-time three-dimensional transesphageal echocardiography in evaluaying on morphology and mechanical function of left atrial appendage in patients with non-valvular atrial fibrillation. Chinese Journal of Medical Imaging Technology. 10:1616–1620. 2013.

15 

Meng FX, Chen M, Sun JP and Dong Y: The assessment of left atrial appendage function in patients at high risk of thrombosis through transesophageal echocardiography. Chinese J Medical Imaging Technol. 6:473–479. 2014.

16 

Shimizu T, Takada T, Shimode A, Fujita Y, Usuki N, Kato B, Takaishi S, Hirayama T, Hanzawa K and Hasegawa Y: Association between paroxysmal atrial fibrillation and the left atrial appendage ejection fraction during sinus rhythm in the acute stage of stroke: a transesophageal echocardiographic study. J Stroke Cerebrovasc Dis. 22:1370–1376. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gan L, Yu L, Xie M, Feng W and Yin J: Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation. Exp Ther Med 12: 3323-3327, 2016.
APA
Gan, L., Yu, L., Xie, M., Feng, W., & Yin, J. (2016). Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation. Experimental and Therapeutic Medicine, 12, 3323-3327. https://doi.org/10.3892/etm.2016.3745
MLA
Gan, L., Yu, L., Xie, M., Feng, W., Yin, J."Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation". Experimental and Therapeutic Medicine 12.5 (2016): 3323-3327.
Chicago
Gan, L., Yu, L., Xie, M., Feng, W., Yin, J."Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation". Experimental and Therapeutic Medicine 12, no. 5 (2016): 3323-3327. https://doi.org/10.3892/etm.2016.3745
Copy and paste a formatted citation
x
Spandidos Publications style
Gan L, Yu L, Xie M, Feng W and Yin J: Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation. Exp Ther Med 12: 3323-3327, 2016.
APA
Gan, L., Yu, L., Xie, M., Feng, W., & Yin, J. (2016). Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation. Experimental and Therapeutic Medicine, 12, 3323-3327. https://doi.org/10.3892/etm.2016.3745
MLA
Gan, L., Yu, L., Xie, M., Feng, W., Yin, J."Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation". Experimental and Therapeutic Medicine 12.5 (2016): 3323-3327.
Chicago
Gan, L., Yu, L., Xie, M., Feng, W., Yin, J."Analysis of real-time three dimensional transesophageal echocardiography in the assessment of left atrial appendage function in patients with atrial fibrillation". Experimental and Therapeutic Medicine 12, no. 5 (2016): 3323-3327. https://doi.org/10.3892/etm.2016.3745
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team